Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Robert Mak

    Address9500 Gilman Drive #0630
    CA La Jolla 92093
    Phone858-822-6717
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Cheung WW, Hao S, Mak R. Emerging roles of nuclear phosphatase SCP4 in CKD-associated muscle wasting. Kidney Int. 2017 Aug; 92(2):281-283. PMID: 28709594.
        View in: PubMed
      2. Mak R, Cheung WW. MicroRNA as Novel Exercise Mimetic for Muscle Wasting in CKD. J Am Soc Nephrol. 2017 Sep; 28(9):2557-2559. PMID: 28720683.
        View in: PubMed
      3. Fuhrman DY, Schneider MF, Dell KM, Blydt-Hansen TD, Mak R, Saland JM, Furth SL, Warady BA, Moxey-Mims MM, Schwartz GJ. Albuminuria, Proteinuria, and Renal Disease Progression in Children with CKD. Clin J Am Soc Nephrol. 2017 Jun 07; 12(6):912-920. PMID: 28546440.
        View in: PubMed
      4. Oliveira EA, Cheung WW, Toma KG, Mak R. Muscle wasting in chronic kidney disease. Pediatr Nephrol. 2017 May 15. PMID: 28508131.
        View in: PubMed
      5. Mak R. Cachexia in children with chronic kidney disease: challenges in diagnosis and treatment. Curr Opin Support Palliat Care. 2016 Dec; 10(4):293-297. PMID: 27258684.
        View in: PubMed
      6. Tu J, Cheung WW, Mak R. Inflammation and nutrition in children with chronic kidney disease. World J Nephrol. 2016 May 6; 5(3):274-82. PMID: 27152263.
        View in: PubMed
      7. Oliveira EA, Oliveira MC, Mak R. Evaluation and management of hydronephrosis in the neonate. Curr Opin Pediatr. 2016 Apr; 28(2):195-201. PMID: 26807623.
        View in: PubMed
      8. Floege J, Mak R, Molitoris BA, Remuzzi G, Ronco P. Nephrology research-the past, present and future. Nat Rev Nephrol. 2015 Nov; 11(11):677-87. PMID: 26416499.
        View in: PubMed
      9. Cheung WW, Cherqui S, Ding W, Esparza M, Zhou P, Shao J, Lieber RL, Mak R. Muscle wasting and adipose tissue browning in infantile nephropathic cystinosis. J Cachexia Sarcopenia Muscle. 2016 May; 7(2):152-64. PMID: 27493869.
        View in: PubMed
      10. Mak R, Hoffman HM. Transplantation: Outcomes of prenatal immunosuppression. Nat Rev Nephrol. 2015 Jul; 11(7):390-1. PMID: 25986424.
        View in: PubMed
      11. Ding W, Cheung WW, Mak R. Impact of obesity on kidney function and blood pressure in children. World J Nephrol. 2015 May 6; 4(2):223-9. PMID: 25949935.
        View in: PubMed
      12. Warady BA, Abraham AG, Schwartz GJ, Wong CS, Muñoz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak R, Flynn J, Moxey-Mims MM, Furth S. Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort. Am J Kidney Dis. 2015 Jun; 65(6):878-88. PMID: 25799137.
        View in: PubMed
      13. Lemley KV, Mak R. Nephrotic syndrome: Efficacy of rituximab in challenging nephrotic syndrome. Nat Rev Nephrol. 2015 May; 11(5):257-8. PMID: 25752834.
        View in: PubMed
      14. Mak R, Cheung WW, Gertler A. Exploiting the therapeutic potential of leptin signaling in cachexia. Curr Opin Support Palliat Care. 2014 Dec; 8(4):352-7. PMID: 25259544.
        View in: PubMed
      15. Ding W, Mak R. Early markers of obesity-related renal injury in childhood. Pediatr Nephrol. 2015 Jan; 30(1):1-4. PMID: 25322907.
        View in: PubMed
      16. Mak R, Schaefer F. Chronic kidney disease: Prenatal risk factors for kidney and urinary tract anomalies. Nat Rev Nephrol. 2014 Aug; 10(8):428-9. PMID: 24935706.
        View in: PubMed
      17. Ingulli EG, Mak R. Growth in children with chronic kidney disease: role of nutrition, growth hormone, dialysis, and steroids. Curr Opin Pediatr. 2014 Apr; 26(2):187-92. PMID: 24535500.
        View in: PubMed
      18. Lee B, Qiao L, Lu M, Yoo HS, Cheung W, Mak R, Schaack J, Feng GS, Chi NW, Olefsky JM, Shao J. C/EBPa regulates macrophage activation and systemic metabolism. Am J Physiol Endocrinol Metab. 2014 May 15; 306(10):E1144-54. PMID: 24691027.
        View in: PubMed
      19. Abraham AG, Mak R, Mitsnefes M, White C, Moxey-Mims M, Warady B, Furth SL. Protein energy wasting in children with chronic kidney disease. Pediatr Nephrol. 2014 Jul; 29(7):1231-8. PMID: 24504731.
        View in: PubMed
      20. Cheung WW, Ding W, Gunta SS, Gu Y, Tabakman R, Klapper LN, Gertler A, Mak R. A Pegylated Leptin Antagonist Ameliorates CKD-Associated Cachexia in Mice. J Am Soc Nephrol. 2014 Jan; 25(1):119-28. PMID: 24115476.
        View in: PubMed
      21. Mak R, Smoyer WE. Nephrotic syndrome: Genetic screening in steroid-resistant nephrotic syndrome. Nat Rev Nephrol. 2013 Jul; 9(7):379-81. PMID: 23689120.
        View in: PubMed
      22. Gunta SS, Thadhani RI, Mak R. The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev Nephrol. 2013 Jun; 9(6):337-47. PMID: 23609564.
        View in: PubMed
      23. Gunta SS, Mak R. Ghrelin and leptin pathophysiology in chronic kidney disease. Pediatr Nephrol. 2013 Apr; 28(4):611-6. PMID: 23229444.
        View in: PubMed
      24. Mak R, Warady BA. Dialysis: Vascular access in children--arteriovenous fistula or CVC? Nat Rev Nephrol. 2013 Jan; 9(1):9-11. PMID: 23183841.
        View in: PubMed
      25. Gunta SS, Mak R. Is obesity a risk factor for chronic kidney disease in children? Pediatr Nephrol. 2013 Oct; 28(10):1949-56. PMID: 23150030.
        View in: PubMed
      26. Carter CE, Shayan K, Mak R, Yorgin PD, Krous HF. Nephrotic syndrome in an 18-year-old boy with congenital myelomeningocele: questions. Pediatr Nephrol. 2013 Oct; 28(10):1963-4, 1965-7. PMID: 23135608.
        View in: PubMed
      27. Cheung WW, Mak R. Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease. Am J Physiol Renal Physiol. 2012 Nov 1; 303(9):F1315-24. PMID: 22914778.
        View in: PubMed
      28. Mak R, Cheung WW. MicroRNAs: a new therapeutic frontier for muscle wasting in chronic kidney disease. Kidney Int. 2012 Aug; 82(4):373-4. PMID: 22846810.
        View in: PubMed
      29. Mak R. Serum myostatin in patients on maintenance haemodialysis: a useful biomarker of muscle wasting?. Clin Endocrinol (Oxf). 2011 Dec; 75(6):738-9. PMID: 21913953.
        View in: PubMed
      30. Rees L, Mak R. Nutrition and growth in children with chronic kidney disease. Nat Rev Nephrol. 2011 Nov; 7(11):615-23. PMID: 21947116.
        View in: PubMed
      31. Foster BJ, McCauley L, Mak R. Nutrition in infants and very young children with chronic kidney disease. Pediatr Nephrol. 2012 Sep; 27(9):1427-39. PMID: 21874586.
        View in: PubMed
      32. Furth SL, Abraham AG, Jerry-Fluker J, Schwartz GJ, Benfield M, Kaskel F, Wong C, Mak R, Moxey-Mims M, Warady BA. Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol. 2011 Sep; 6(9):2132-40. PMID: 21841064.
        View in: PubMed
      33. Mak R, Ikizler TA, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K. Erratum to: Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2011 Jun; 2(2):119. PMID: 22477651.
        View in: PubMed
      34. Kalantar-Zadeh K, Cano NJ, Budde K, Chazot C, Kovesdy CP, Mak R, Mehrotra R, Raj DS, Sehgal AR, Stenvinkel P, Ikizler TA. Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol. 2011 Jul; 7(7):369-84. PMID: 21629229.
        View in: PubMed
      35. Ishikura K, Hamasaki Y, Sakai T, Hataya H, Mak R, Honda M. Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol. 2012 Mar; 27(3):375-84. PMID: 21556718.
        View in: PubMed
      36. Mak R, Cheung WW. Is ghrelin a biomarker for mortality in end-stage renal disease? Kidney Int. 2011 Apr; 79(7):697-9. PMID: 21403653.
        View in: PubMed
      37. Mak R, Ikizler AT, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K. Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2011 Mar; 2(1):9-25. PMID: 21475675.
        View in: PubMed
      38. Mak R, Cheung WW, Zhan JY, Shen Q, Foster BJ. Cachexia and protein-energy wasting in children with chronic kidney disease. Pediatr Nephrol. 2012 Feb; 27(2):173-81. PMID: 21298504.
        View in: PubMed
      39. Cheung WW, Zhan JY, Paik KH, Mak R. The impact of inflammation on bone mass in children. Pediatr Nephrol. 2011 Nov; 26(11):1937-46. PMID: 21197596.
        View in: PubMed
      40. Querfeld U, Mak R. Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window. Pediatr Nephrol. 2010 Dec; 25(12):2413-30. PMID: 20567854.
        View in: PubMed
      41. Santos F, Kaskel FJ, Mak R, Caldas A. 8th International Symposium on Growth and Nutrition in Children with Chronic Renal Disease: 28-30 May 2009, Oviedo, Asturias, Spain. Pediatr Nephrol. 2010 Apr; 25(4):581-2. PMID: 20013292.
        View in: PubMed
      42. Cheung WW, Mak R. Ghrelin in chronic kidney disease. Int J Pept. 2010; 2010. PMID: 20721357.
        View in: PubMed
      43. Mak R, Bakris G. Pediatrics: Masked hypertension: a risk factor in children with CKD. Nat Rev Nephrol. 2010 Mar; 6(3):132-4. PMID: 20186228.
        View in: PubMed
      44. Mak R, Flynn J, Bakris G. Pediatrics: blood pressure target for renoprotection in children. Nat Rev Nephrol. 2010 Feb; 6(2):67-8. PMID: 20111045.
        View in: PubMed
      45. Cheung WW, Paik KH, Mak R. Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol. 2010 Apr; 25(4):711-24. PMID: 20111974.
        View in: PubMed
      46. Cheung WW, Mak R. Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease. Kidney Int. 2009 Jul; 76(2):135-7. PMID: 19564855.
        View in: PubMed
      47. Wong CS, Pierce CB, Cole SR, Warady BA, Mak R, Benador NM, Kaskel F, Furth SL, Schwartz GJ. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol. 2009 Apr; 4(4):812-9. PMID: 19297612.
        View in: PubMed
      48. Mak R. Recent advances in chronic dialysis and renal transplantation in children. Pediatr Nephrol. 2009 Mar; 24(3):459-61. PMID: 19153772.
        View in: PubMed
      49. Schwartz GJ, Muñoz A, Schneider MF, Mak R, Kaskel F, Warady BA, Furth SL. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009 Mar; 20(3):629-37. PMID: 19158356.
        View in: PubMed
      50. Mak R. Acute kidney injury in children: the dawn of a new era. Pediatr Nephrol. 2008 Dec; 23(12):2147-9. PMID: 18936981.
        View in: PubMed
      51. Cheung WW, Rosengren S, Boyle DL, Mak R. Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int. 2008 Jul; 74(2):180-6. PMID: 18432186.
        View in: PubMed
      52. Mak R, Cheung W. Therapeutic strategy for cachexia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2007 Nov; 16(6):542-6. PMID: 18089968.
        View in: PubMed
      53. Mak R, Wong JH. Are oral antibiotics alone efficacious for the treatment of a first episode of acute pyelonephritis in children? Nat Clin Pract Nephrol. 2008 Jan; 4(1):10-1. PMID: 17971799.
        View in: PubMed
      54. Mak R. Insulin and its role in chronic kidney disease. Pediatr Nephrol. 2008 Mar; 23(3):355-62. PMID: 17929061.
        View in: PubMed
      55. Mak R, Cheung WW, Roberts CT. The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res. 2008 Feb; 18(1):17-25. PMID: 17826224.
        View in: PubMed
      56. Cheung WW, Kuo HJ, Markison S, Chen C, Foster AC, Marks DL, Mak R. Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol. 2007 Sep; 18(9):2517-24. PMID: 17687077.
        View in: PubMed
      57. Mak R, Cheung W. Adipokines and gut hormones in end-stage renal disease. Perit Dial Int. 2007 Jun; 27 Suppl 2:S298-302. PMID: 17556323.
        View in: PubMed
      58. Wahba IM, Mak R. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007 May; 2(3):550-62. PMID: 17699463.
        View in: PubMed
      59. Mak R, Cheung W. Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens. 2007 Jan; 16(1):27-31. PMID: 17143068.
        View in: PubMed
      60. Mak R, Cheung W, Purnell J. Ghrelin in chronic kidney disease: too much or too little? Perit Dial Int. 2007 Jan-Feb; 27(1):51-5. PMID: 17179511.
        View in: PubMed
      61. Mak R. Chronic kidney disease in children: state of the art. Pediatr Nephrol. 2007 Oct; 22(10):1687-8. PMID: 17086403.
        View in: PubMed
      62. Mak R, Proesmans W, Trachtman H. Teaching articles: a new goal of the journal. Pediatr Nephrol. 2007 Jan; 22(1):24-5. PMID: 17086404.
        View in: PubMed
      63. Mak R. Can plasma iohexol disappearance be used to measure GFR in children with chronic kidney disease? Nat Clin Pract Nephrol. 2006 Nov; 2(11):608-9. PMID: 17066046.
        View in: PubMed
      64. Mak R, Kuo HJ, Cheung WW. Animal models of obesity-associated chronic kidney disease. Adv Chronic Kidney Dis. 2006 Oct; 13(4):374-85. PMID: 17045223.
        View in: PubMed
      65. Mak R, Cheung W, Cone RD, Marks DL. Mechanisms of disease: Cytokine and adipokine signaling in uremic cachexia. Nat Clin Pract Nephrol. 2006 Sep; 2(9):527-34. PMID: 16941045.
        View in: PubMed
      66. Mak R, Rotwein P. Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation. Kidney Int. 2006 Aug; 70(3):410-2. PMID: 16871252.
        View in: PubMed
      67. Mak R, Cheung W. Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol. 2006 Dec; 21(12):1807-14. PMID: 16897005.
        View in: PubMed
      68. Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, Wong C, Muñoz A, Warady BA. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol. 2006 Sep; 1(5):1006-15. PMID: 17699320.
        View in: PubMed
      69. Mak R, Kuo HJ. Pathogenesis of urinary tract infection: an update. Curr Opin Pediatr. 2006 Apr; 18(2):148-52. PMID: 16601494.
        View in: PubMed
      70. Mak R, Cheung W, Cone RD, Marks DL. Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int. 2006 Mar; 69(5):794-7. PMID: 16518340.
        View in: PubMed
      71. Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak R. Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest. 2005 Jun; 115(6):1659-65. PMID: 15931394.
        View in: PubMed
      72. Mak R, Cheung W, Cone RD, Marks DL. Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatr Nephrol. 2005 Mar; 20(3):427-31. PMID: 15662537.
        View in: PubMed
      73. Mak R, Chang SL, Draksharapu A, Pak YK. Gene expression in uremic left ventricular hypertrophy: effects of hypertension and anemia. Exp Mol Med. 2004 Jun 30; 36(3):251-8. PMID: 15272237.
        View in: PubMed
      74. Mak R, Chang SL, Pak YK. Growth impairment of primary chondrocyte cells by serum of rats with chronic renal failure. Exp Mol Med. 2004 Jun 30; 36(3):243-50. PMID: 15272236.
        View in: PubMed
      75. Mak R, Kuo HJ. Primary ureteral reflux: emerging insights from molecular and genetic studies. Curr Opin Pediatr. 2003 Apr; 15(2):181-5. PMID: 12640275.
        View in: PubMed
      76. De Backer J, Mak R, De Bacquer D, Van Renterghem L, Verbraekel E, Kornitzer M, De Backer G. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis. 2002 Feb; 160(2):457-63. PMID: 11849671.
        View in: PubMed
      77. Mak R. Impact of end-stage renal disease and dialysis on glycemic control. Semin Dial. 2000 Jan-Feb; 13(1):4-8. PMID: 10740665.
        View in: PubMed
      78. Mak R. Effect of metabolic acidosis on hyperlipidemia in uremia. Pediatr Nephrol. 1999 Nov; 13(9):891-3. PMID: 10603143.
        View in: PubMed
      79. Mak R. Effect of metabolic acidosis on branched-chain amino acids in uremia. Pediatr Nephrol. 1999 May; 13(4):319-22. PMID: 10454782.
        View in: PubMed
      80. Mak R. Metabolic effects of erythropoietin in patients on peritoneal dialysis. Pediatr Nephrol. 1998 Oct; 12(8):660-5. PMID: 9811391.
        View in: PubMed
      81. Mak R. Insulin, branched-chain amino acids, and growth failure in uremia. Pediatr Nephrol. 1998 Oct; 12(8):637-42. PMID: 9811385.
        View in: PubMed
      82. Mak R. Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int. 1998 Aug; 54(2):603-7. PMID: 9690228.
        View in: PubMed
      83. Mak R. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int. 1998 May; 53(5):1353-7. PMID: 9573552.
        View in: PubMed
      84. Alfrey EJ, Salvatierra O, Tanney DC, Mak R, Scandling JD, Dafoe DC, Hammer GB, Orlandi PD, Page L, Conley SB. Bladder augmentation can be problematic with renal failure and transplantation. Pediatr Nephrol. 1997 Dec; 11(6):672-5. PMID: 9438639.
        View in: PubMed
      85. Salvatierra O, Alfrey E, Tanney DC, Mak R, Hammer GB, Krane EJ, So SK, Lemley K, Orlandi PD, Conley SB. Superior outcomes in pediatric renal transplantation. Arch Surg. 1997 Aug; 132(8):842-7; discussion 847-9. PMID: 9267267.
        View in: PubMed
      86. Beutels M, Van Damme P, Aelvoet W, Desmyter J, Dondeyne F, Goilav C, Mak R, Muylle L, Pierard D, Stroobant A, Van Loock F, Waumans P, Vranckx R. Prevalence of hepatitis A, B and C in the Flemish population. Eur J Epidemiol. 1997 Apr; 13(3):275-80. PMID: 9258525.
        View in: PubMed
      87. Mak R, Mehls O. Insulin-like growth factor-I action on glucose transport in acute renal failure. Am J Physiol. 1996 Aug; 271(2 Pt 2):F440-5. PMID: 8770177.
        View in: PubMed
      88. Mak R, Pak YK. End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure. Kidney Int. 1996 Aug; 50(2):400-6. PMID: 8840266.
        View in: PubMed
      89. Mak R. Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia. J Pediatr. 1996 Jul; 129(1):97-104. PMID: 8757568.
        View in: PubMed
      90. Mak R. Insulin resistance but IGF-I sensitivity in chronic renal failure. Am J Physiol. 1996 Jul; 271(1 Pt 2):F114-9. PMID: 8760251.
        View in: PubMed
      91. Mak R. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol. 1996 May; 270(5 Pt 2):F839-44. PMID: 8928846.
        View in: PubMed
      92. Mak R. Insulin secretion and growth failure in uremia. Pediatr Res. 1995 Sep; 38(3):379-83. PMID: 7494663.
        View in: PubMed
      93. Mak R, Haycock GB, Chantler C. Insulin and growth in chronic renal failure. Pediatr Nephrol. 1994 Jun; 8(3):309-12. PMID: 7917856.
        View in: PubMed
      94. Mak R. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol. 1992 Jul; 6(4):345-8. PMID: 1498003.
        View in: PubMed
      95. Mak R. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int. 1992 Apr; 41(4):1049-54. PMID: 1513086.
        View in: PubMed
      96. Mak R, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron. 1992; 61(4):377-82. PMID: 1501732.
        View in: PubMed
      97. Mak R, Wong JH. The vitamin D/parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia. Miner Electrolyte Metab. 1992; 18(2-5):156-9. PMID: 1465050.
        View in: PubMed
      98. Karpati RM, Mak R, Lemley KV. Hypercalcemia, hypertension and acute renal insufficiency in an immobilized adolescent. Child Nephrol Urol. 1991; 11(4):215-9. PMID: 1777905.
        View in: PubMed
      99. Friedman AL, Heiliczer JD, Gundberg CM, Mak R, Boineau FG, McEnery PT, Chan JC. Serum osteocalcin concentrations in children with chronic renal insufficiency who are not undergoing dialysis. Growth Failure in Children with Renal Diseases Study. J Pediatr. 1990 Feb; 116(2):S55-9. PMID: 2405137.
        View in: PubMed
      100. Mak R. Insulin secretion in uremia: effect of parathyroid hormone and vitamin D metabolites. Kidney Int Suppl. 1989 Nov; 27:S227-30. PMID: 2699996.
        View in: PubMed
      101. Mak R. Carbohydrate metabolism in uremia. Pediatr Nephrol. 1989 Apr; 3(2):201-8. PMID: 2701869.
        View in: PubMed
      102. Turner C, Compston J, Mak R, Vedi S, Mellish RW, Haycock GB, Chantler C. Bone turnover and 1,25-dihydroxycholecalciferol during treatment with phosphate binders. Kidney Int. 1988 May; 33(5):989-95. PMID: 3392888.
        View in: PubMed
      103. Tamanaha K, Mak R, Rigden SP, Turner C, Start KM, Haycock GB, Chantler C. Long-term suppression of hyperparathyroidism by phosphate binders in uremic children. Pediatr Nephrol. 1987 Apr; 1(2):145-9. PMID: 3153271.
        View in: PubMed
      104. Mak R, Turner C, Thompson T, Powell H, Haycock GB, Chantler C. Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide. Br Med J (Clin Res Ed). 1985 Sep 7; 291(6496):623-7. PMID: 3928054.
        View in: PubMed
      105. Mak R, Bettinelli A, Turner C, Haycock GB, Chantler C. The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab. 1985 Feb; 60(2):229-33. PMID: 3880765.
        View in: PubMed
      106. Mak R, Haycock GB, Chantler C. Glucose intolerance in children with chronic renal failure. Kidney Int Suppl. 1983 Nov; 15:S22-6. PMID: 6368948.
        View in: PubMed
      107. Mak R, Al Dahhan J, Azzopardi D, Bosque M, Chantler C, Haycock GB. Measurement of glomerular filtration rate in children after renal transplantation. Kidney Int. 1983 Feb; 23(2):410-3. PMID: 6405074.
        View in: PubMed
      108. Haycock GB, Al-Dahhan J, Mak R, Chantler C. Effect of indomethacin on clinical progress and renal function in cystinosis. Arch Dis Child. 1982 Dec; 57(12):934-9. PMID: 7181523.
        View in: PubMed
      Robert's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _